Company: BLCO
Filing Date: 2025-12-22
Form Type: 8-K/A
Source: 0001860742-25-000035
Chunk: 1

Company: Bausch & Lomb Corp
Filing Date: 2025-12-22
Form: 8-K/A
Chunk 1
---
 of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

#### Emerging growth company
#### ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 17, 2025, Bausch + Lomb Corporation (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) regarding the appointment of Eduardo C. Alfonso, MD and Steven H. Collis to its board of directors (the “Board”), effective January 1, 2026. This Amendment No. 1 to the Initial 8-K is being filed to report that on December 22, 2025, the Board appointed Dr. Alfonso as a member of its Science and Technology Committee and Mr. Collis as a member of its Talent and Compensation Committee, each appointment effective January 1, 2026.

### Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| BAUSCH + LOMB CORPORATION |     |                                                  |
| By:                       |     | /s/A. Robert D. Bailey                           |
| Name:                     |     | A. Robert D. Bailey                              |
| Title:                    |     | Executive Vice President and Chief Legal Officer |

Date: December 22, 2025